Published in Am J Pathol on December 01, 1989
PG-M1: a new monoclonal antibody directed against a fixative-resistant epitope on the macrophage-restricted form of the CD68 molecule. Am J Pathol (1993) 1.81
The use of human CD68 transcriptional regulatory sequences to direct high-level expression of class A scavenger receptor in macrophages in vitro and in vivo. Immunology (2001) 1.46
Monoclonality of smooth muscle cells in human atherosclerosis. Am J Pathol (1997) 1.21
Use of monoclonal antibody KP1 for identifying normal and neoplastic human mast cells. J Clin Pathol (1990) 1.15
Expression of vascular cell adhesion molecule (VCAM-1) in liver and pancreas allograft rejection. Am J Pathol (1993) 1.03
Identification of CD68(+) neutrophil granulocytes in in vitro model of acute inflammation and inflammatory bowel disease. Int J Clin Exp Pathol (2013) 0.84
The macrophage A2B adenosine receptor regulates tissue insulin sensitivity. PLoS One (2014) 0.82
CD68 reactivity of non-macrophage derived tumours in cytological specimens. J Clin Pathol (1993) 0.78
Telocytes: a potential defender in the spleen of Npc1 mutant mice. J Cell Mol Med (2016) 0.75
Relapse of acute myeloid leukemia manifested by cholecystitis: A case report and review of the literature. Int J Surg Case Rep (2014) 0.75
A new monoclonal antibody (3A5) that recognises a fixative resistant epitope on tissue macrophages and monocytes. J Clin Pathol (1994) 0.75
Innate immune reactions in locally limited tonsillar cancer. Eur Arch Otorhinolaryngol (2013) 0.75
Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). J Histochem Cytochem (1984) 18.48
Esterases in human leukocytes. J Histochem Cytochem (1973) 7.37
Granulocytic sarcoma: a clinicopathologic study of 61 biopsied cases. Cancer (1981) 5.89
The use of proteolytic enzymes to improve immunoglobulin staining by the PAP technique. Histochem J (1979) 4.06
Updated Kiel classification for lymphomas. Lancet (1988) 3.25
KP1: a new monoclonal antibody that detects a monocyte/macrophage associated antigen in routinely processed tissue sections. J Clin Pathol (1989) 2.82
Monoclonal antibody EBM/11: high cellular specificity for human macrophages. J Clin Pathol (1988) 2.44
Monoclonal antibody (UCHL1) that recognises normal and neoplastic T cells in routinely fixed tissues. J Clin Pathol (1986) 2.24
Two new monoclonal antibodies (LN-1, LN-2) reactive in B5 formalin-fixed, paraffin-embedded tissues with follicular center and mantle zone human B lymphocytes and derived tumors. J Immunol (1984) 2.18
Immunohistological analysis of human lymphoma: correlation of histological and immunological categories. Adv Cancer Res (1984) 2.03
Identification of resting human T and B lymphocytes by acid alpha-naphthyl acetate esterase staining combined with rosette formation with Staphylococcus aureus strain Cowan 1. Scand J Immunol (1976) 1.91
Monocyte/macrophage-reactive monoclonal antibody Ki-M6 recognizes an intracytoplasmic antigen. Am J Pathol (1986) 1.72
Monoclonal antibodies (MT1, MT2, MB1, MB2, MB3) reactive with leukocyte subsets in paraffin-embedded tissue sections. Am J Pathol (1987) 1.71
A human macrophage-associated antigen (CD68) detected by six different monoclonal antibodies. Br J Haematol (1989) 1.64
Acid esterase in human lymphoid cells and leukaemic blasts: a marker for T lymphocytes. Br J Haematol (1977) 1.59
The demonstration of acid alpha-naphthyl acetate esterase activity in human lymphocytes: usefulness as a T-cell marker. Cell Immunol (1978) 1.52
Monoclonal antibody (Y1/82A) with specificity towards peripheral blood monocytes and tissue macrophages. J Clin Pathol (1988) 1.41
Utilization of monoclonal antibody L26 in the identification and confirmation of B-cell lymphomas. A sensitive and specific marker applicable to formalin-and B5-fixed, paraffin-embedded tissues. Am J Pathol (1987) 1.39
Ultrastructure and cytochemistry of human peripheral blood lymphocytes. Similarities between the cells of the third population and TG lymphocytes. Eur J Immunol (1980) 1.38
Immunophenotypic diagnosis of non-Hodgkin's lymphoma in paraffin sections. Co-expression of L60 (Leu-22) and L26 antigens correlates with malignant histologic findings. Am J Clin Pathol (1989) 1.34
Two distinct antigen systems in human B lymphocytes: identification of cell surface and intracellular antigens using monoclonal antibodies. Clin Exp Immunol (1984) 1.32
Malignant lymphoma and erythrophagocytosis simulating malignant histiocytosis. Am J Med (1983) 1.27
Monoclonal antibody L26: an antibody that is reactive with normal and neoplastic B lymphocytes in routinely fixed and paraffin wax embedded tissues. J Clin Pathol (1987) 1.24
Immunophenotyping of non-Hodgkin's lymphomas using a panel of antibodies on paraffin-embedded tissues. Am J Pathol (1987) 1.23
Histiocytic malignancies. Morphologic, immunologic, and enzymatic heterogeneity. Am J Surg Pathol (1984) 1.21
Coexpression of epithelial membrane antigen (EMA), Ki-1, and interleukin-2 receptor by anaplastic large cell lymphomas. Diagnostic value in so-called malignant histiocytosis. Am J Pathol (1988) 1.21
Frequent immunoglobulin and T-cell receptor gene rearrangements in "histiocytic" neoplasms. Am J Pathol (1985) 1.07
The E rosette-associated antigen of T cells can be identified on blasts from patients with acute myeloblastic leukemia. Blood (1985) 1.03
Malignant lymphoma obscured by concomitant extensive epithelioid granulomas: report of three cases with similar clinicopathologic features. Cancer (1977) 0.97
Immunohistochemical staining of non-Hodgkin's lymphoma in paraffin sections using the MB1 and MT1 monoclonal antibodies. J Pathol (1987) 0.96
Immunologic phenotypes of diffuse, aggressive, non-Hodgkin's lymphomas. Correlation with clinical features. Cancer (1984) 0.94
Monoclonal antibodies reactive in routinely processed tissue sections of malignant lymphoma, with emphasis on T-cell lymphomas. Hum Pathol (1987) 0.93
Genotypic analysis of large cell lymphomas which express the Ki-1 antigen. Histopathology (1987) 0.90
Large-cell hematolymphoid neoplasms of uncertain lineage. Hum Pathol (1988) 0.89
Extramedullary masses as presenting features of acute monoblastic leukemia. Am J Clin Pathol (1981) 0.85
Expression of monocytic--histiocytic cytochemical markers in epithelial neoplasia. Am J Clin Pathol (1979) 0.85
Immunocytochemical characterisation of cutaneous lymphomas other than mycosis fungoides. J Clin Pathol (1986) 0.83
Acid alpha-naphthyl acetate esterase activity in human neoplastic lymphoid cells. Usefulness as a T-cell marker. Am J Pathol (1979) 0.79
Diagnosis of acute myeloid leukaemia with the use of monoclonal anti-neutrophil elastase (NP57) reactive with routinely processed biopsy samples. Histopathology (1989) 0.78
EBM/11 reactivity in malignant histiocytosis. J Clin Pathol (1988) 0.77
Acid alpha-naphthyl acetate esterase in hairy cell leukemia cells and other cells of the hematopoietic system. Blut (1979) 0.77
A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood (1994) 21.00
Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). J Histochem Cytochem (1984) 18.48
An immunohistochemical study of the pathology of fatal malaria. Evidence for widespread endothelial activation and a potential role for intercellular adhesion molecule-1 in cerebral sequestration. Am J Pathol (1994) 5.34
The expression and distribution of the hypoxia-inducible factors HIF-1alpha and HIF-2alpha in normal human tissues, cancers, and tumor-associated macrophages. Am J Pathol (2000) 5.21
A human thymocyte antigen defined by a hybrid myeloma monoclonal antibody. Eur J Immunol (1979) 5.17
Expression of the bcl-2 oncogene protein is not specific for the 14;18 chromosomal translocation. Am J Pathol (1990) 4.42
Tumours of histiocytes and accessory dendritic cells: an immunohistochemical approach to classification from the International Lymphoma Study Group based on 61 cases. Histopathology (2002) 4.22
bcl-2 protein in non-small-cell lung carcinoma. N Engl J Med (1993) 4.05
The distribution of muramidase (lysozyme) in human tissues. J Clin Pathol (1975) 4.03
Induction of endothelial PAS domain protein-1 by hypoxia: characterization and comparison with hypoxia-inducible factor-1alpha. Blood (1998) 3.67
Diagnosis of human lymphoma with monoclonal antileukocyte antibodies. N Engl J Med (1983) 3.63
Ki67 protein: the immaculate deception? Histopathology (2002) 3.61
The Bloom's syndrome gene product interacts with topoisomerase III. J Biol Chem (2000) 3.52
Transferrin receptor on endothelium of brain capillaries. Nature (1984) 3.37
Alkaline phosphatase and peroxidase for double immunoenzymatic labelling of cellular constituents. J Clin Pathol (1978) 3.36
Hypokalemia from beta2-receptor stimulation by circulating epinephrine. N Engl J Med (1983) 3.27
Transferrin receptors in human tissues: their distribution and possible clinical relevance. J Clin Pathol (1983) 3.23
Expression of HLA-DR antigens by colonic epithelium in inflammatory bowel disease. Clin Exp Immunol (1983) 3.21
The normal and malignant germinal centre. Clin Haematol (1982) 3.19
Relation of hypoxia inducible factor 1 alpha and 2 alpha in operable non-small cell lung cancer to angiogenic/molecular profile of tumours and survival. Br J Cancer (2001) 3.10
JC70: a new monoclonal antibody that detects vascular endothelium associated antigen on routinely processed tissue sections. J Clin Pathol (1990) 3.10
Monoclonal antibody Ki-67: its use in histopathology. Histopathology (1990) 3.07
Immunocytochemical localization of the cystic fibrosis gene product CFTR. Proc Natl Acad Sci U S A (1991) 2.82
KP1: a new monoclonal antibody that detects a monocyte/macrophage associated antigen in routinely processed tissue sections. J Clin Pathol (1989) 2.82
Prognostic significance of a novel hypoxia-regulated marker, carbonic anhydrase IX, in invasive breast carcinoma. J Clin Oncol (2001) 2.71
Germinal center cells express bcl-2 protein after activation by signals which prevent their entry into apoptosis. Eur J Immunol (1991) 2.71
Use of monoclonal antibodies for the histopathological diagnosis of human malignancy. J Clin Pathol (1982) 2.69
On the Incidence of Cystic Fibrosis of the Pancreas. Am J Hum Genet (1960) 2.67
Epstein-Barr virus and Hodgkin's disease: transcriptional analysis of virus latency in the malignant cells. J Exp Med (1993) 2.56
Quantitation and prognostic value of breast cancer angiogenesis: comparison of microvessel density, Chalkley count, and computer image analysis. J Pathol (1995) 2.52
Identification of Hodgkin and Sternberg-reed cells as a unique cell type derived from a newly-detected small-cell population. Int J Cancer (1982) 2.51
Ultrastructural localization of bcl-2 protein. J Histochem Cytochem (1992) 2.48
Immunohistological analysis of human mononuclear phagocytes and dendritic cells by using monoclonal antibodies. Lab Invest (1986) 2.42
Clinical use of the 193-nm excimer laser in the treatment of corneal scars. Arch Ophthalmol (1991) 2.41
ALK-positive lymphoma: a single disease with a broad spectrum of morphology. Blood (1998) 2.41
Peripheral T-cell lymphoma associated with hemophagocytic syndrome. Blood (1990) 2.40
Clinical importance of analysing malignant tumours of uncertain origin with immunohistological techniques. Lancet (1985) 2.40
Urokinase-type plasminogen activator is expressed in stromal cells and its receptor in cancer cells at invasive foci in human colon adenocarcinomas. Am J Pathol (1991) 2.38
Expression of hypoxia-inducible carbonic anhydrase-9 relates to angiogenic pathways and independently to poor outcome in non-small cell lung cancer. Cancer Res (2001) 2.38
Clinical evaluation of trifluorothymidine in the treatment of herpes simplex corneal ulcers. Am J Ophthalmol (1972) 2.37
Epstein-Barr virus-associated Hodgkin's disease: epidemiologic characteristics in international data. Int J Cancer (1997) 2.30
Malignant histiocytosis of the intestine: a T-cell lymphoma. Lancet (1985) 2.25
Human lymphoid cells express epithelial membrane antigen. Implications for diagnosis of human neoplasms. Lancet (1984) 2.25
Use of freeze-dried paraffin-embedded sections for immunohistologic staining with monoclonal antibodies. Lab Invest (1985) 2.23
Normal human tissues, in addition to some tumors, express multiple different CD44 isoforms. Cancer Res (1994) 2.21
Lactate dehydrogenase-5 (LDH-5) overexpression in non-small-cell lung cancer tissues is linked to tumour hypoxia, angiogenic factor production and poor prognosis. Br J Cancer (2003) 2.20
Undiagnosed glucose intolerance in the community: the Isle of Ely Diabetes Project. Diabet Med (1995) 2.20
Association between platelet microthrombi and finger clubbing. Lancet (1991) 2.20
Non-small-cell lung carcinoma tumor growth without morphological evidence of neo-angiogenesis. Am J Pathol (1997) 2.19
Immunocytochemical detection of T and B cell populations in routine blood smears. Lancet (1984) 2.17
Comparison of effects of elective tenectomy or onychectomy in cats. J Am Vet Med Assoc (1998) 2.13
Systemic endothelial activation occurs in both mild and severe malaria. Correlating dermal microvascular endothelial cell phenotype and soluble cell adhesion molecules with disease severity. Am J Pathol (1998) 2.05
Role of the nucleophosmin (NPM) portion of the non-Hodgkin's lymphoma-associated NPM-anaplastic lymphoma kinase fusion protein in oncogenesis. Mol Cell Biol (1997) 2.04
Molecular cloning of ICAM-3, a third ligand for LFA-1, constitutively expressed on resting leukocytes. Nature (1992) 2.03
Immunohistological analysis of human lymphoma: correlation of histological and immunological categories. Adv Cancer Res (1984) 2.03
The structure of the human CD2 gene and its expression in transgenic mice. EMBO J (1988) 2.00
Laminin-5 is a marker of invading cancer cells in some human carcinomas and is coexpressed with the receptor for urokinase plasminogen activator in budding cancer cells in colon adenocarcinomas. Cancer Res (1995) 1.93
Distribution of the alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein in human tissues. Cell Tissue Res (1992) 1.90
APAAP labelling of blood and bone-marrow samples for phenotyping leukaemia. Lancet (1986) 1.89
Bcl-2 protein expression in follicular lymphomas in absence of 14;18 translocation. Lancet (1990) 1.86
Detection of T cells in paraffin wax embedded tissue using antibodies against a peptide sequence from the CD3 antigen. J Clin Pathol (1989) 1.85
Production of a monoclonal antibody reactive with human dendritic reticulum cells and its use in the immunohistological analysis of lymphoid tissue. J Clin Pathol (1983) 1.85
The immunohistological detection of platelets, megakaryocytes and thrombi in routinely processed specimens. Histopathology (1988) 1.83
Retrovirus-mediated gene transfer of NPM-ALK causes lymphoid malignancy in mice. Blood (1997) 1.83
A new subtype of large B-cell lymphoma expressing the ALK kinase and lacking the 2; 5 translocation. Blood (1997) 1.82
Subcellular localization of the bcl-2 protein in malignant and normal lymphoid cells. Cancer Res (1994) 1.81
bcl-2 in normal human breast and carcinoma, association with oestrogen receptor-positive, epidermal growth factor receptor-negative tumours and in situ cancer. Br J Cancer (1994) 1.81
The gamma 2 chain of kalinin/laminin 5 is preferentially expressed in invading malignant cells in human cancers. Am J Pathol (1994) 1.79
Human complement (C3b) receptors defined by a mouse monoclonal antibody. Immunology (1982) 1.78
Cytokeratin expression in smooth muscle and smooth muscle tumours. Histopathology (1987) 1.78
The immunocytochemical detection of axillary micrometastases in breast cancer. Br J Cancer (1984) 1.77